Log in or Sign up for Free to view tailored content for your specialty!
Cornea/External Disease News
Endodiathermal tautening used for intraoperative floppy iris in EK, PK
Eyes undergoing keratoplasty are often complex and may have already undergone previous surgery. In these cases, the iris may not be completely normal in shape, tone and/or structure.
VIDEO: Iheezo provides new anesthesia option for ocular surgery
KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Maggie Jeffries, MD, shares why Iheezo is a reliable ocular surface anesthetic option and gives tips on how to use it.
Log in or Sign up for Free to view tailored content for your specialty!
Glaukos completes enrollment in second phase 3 epi-on cross-linking trial
Glaukos completed enrollment in the second phase 3 confirmatory pivotal trial for Epioxa, its epi-on corneal cross-linking therapy, according to a press release.
VIDEO: AZR-MD-001 for MGD treatment shows promising study outcomes
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Preeya K. Gupta, MD, presents the results of the phase 2 trial of AZR-MD-001, an ointment for the treatment of meibomian gland dysfunction from Azura Ophthalmics.
VIDEO: Anterion swept-source OCT distinguishes normal eyes, eyes with early ectasia
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Robert Herber, PhD, discusses a study that evaluated the detection of corneal ectasia using Anterion swept-source OCT from Heidelberg Engineering.
VIDEO: Modified grading scale offers precise assessment of corneal fluorescein staining
NEW ORLEANS — At the ARVO meeting, Andrew D. Pucker, OD, PhD, senior director of clinical and medical sciences at Lexitas Pharma Services, speaks about the Lexitas modified NEI grading scale to assess corneal fluorescein staining.
A (sadly) unavoidable review of OTC eye drops
Yes, I am really going to write a column on over-the-counter drops for dry eye disease.
BLOG: Consider the ocular surface in all surgical patients
I think of my clinic as a triad, encompassing three conditions: dry eye disease, glaucoma and cataract.
Tanfanercept fails to meet primary endpoints in phase 3 dry eye trial
Tanfanercept did not demonstrate statistical significance in improvement in central corneal staining score or eye dryness score at week 8, the primary outcome measures of the phase 3 VELOS-3 trial, according to HanAll Biopharma.
VIDEO: Promising results reported for cell therapy in corneal endothelial disease
SAN DIEGO — In this Healio Video Perspective from Eyecelerator@ASCRS, Greg Kunst, CEO of Aurion Biotech, discusses data from the Escalon clinical trial.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read